FDA Drug Chief Departure Signals Leadership Shift at Federal Health Agency
Dr. John Farley, the director of the Office of Infectious Diseases at the FDA’s Center for Drug Evaluation and Research, is departing the agency this week, marking a significant transition within the federal health body. His exit comes amid a broader organizational restructuring and follows a period of intense public and legislative scrutiny regarding the…
